ecteinascidin 743 has been researched along with Bile Duct Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, R; Dinsdale, D; Donald, S; Edwards, R; Gant, TW; Gescher, AJ; Greaves, P; Judah, DJ; Lopez Lazaro, L; Riley, J; Smith, AG; Verschoyle, RD | 1 |
1 other study(ies) available for ecteinascidin 743 and Bile Duct Diseases
Article | Year |
---|---|
Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat.
Topics: Animals; Antineoplastic Agents, Alkylating; Bile Duct Diseases; Bilirubin; Cell Division; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Dioxoles; Female; Gene Expression; Isoquinolines; Liver; Liver Diseases; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin | 2002 |